FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037393671> ?p ?o ?g. }

• W2037393671 endingPage "13" @default.
• W2037393671 startingPage "1" @default.
• W2037393671 abstract "Aims . The aim of the study was to describe and compare (1) the types and prevalence of complementary and alternative medicine (CAM) treatments used among individuals with multiple sclerosis (MS) in the Nordic countries; (2) the types of conventional treatments besides disease-modifying medicine for MS that were used in combination with CAM treatments; (3) the types of symptoms/health issues addressed by use of CAM treatments. Methods. An internet-based questionnaire was used to collect data from 6455 members of the five Nordic MS societies. The response rates varied from 50.9% in Norway to 61.5% in Iceland. Results . A large range of CAM treatments were reported to be in use in all five Nordic countries. Supplements of vitamins and minerals, supplements of oils, special diet, acupuncture, and herbal medicine were among the CAM treatment modalities most commonly used. The prevalence of the overall use of CAM treatments within the last twelve months varied from 46.0% in Sweden to 58.9% in Iceland. CAM treatments were most often used in combination with conventional treatments. The conventional treatments that were most often combined with CAM treatment were prescription medication, physical therapy, and over-the-counter (OTC) medications. The proportion of CAM users who reported exclusive use of CAM (defined as use of no conventional treatments besides disease-modifying medicine for MS) varied from 9.5% in Finland to 18.4% in Norway. In all five Nordic countries, CAM treatments were most commonly used for nonspecific/preventative purposes such as strengthening the body in general, improving the body’s muscle strength, and improving well-being. CAM treatments were less often used for the purpose of improving specific symptoms such as body pain, problems with balance, and fatigue/lack of energy. Conclusions . A large range of CAM treatments were used by individuals with MS in all Nordic countries. The most commonly reported rationale for CAM treatment use focused on improving the general state of health. The overall pattern of CAM treatment use was similar across the five countries." @default.
• W2037393671 created "2016-06-24" @default.
• W2037393671 creator A5002775050 @default.
• W2037393671 creator A5004751866 @default.
• W2037393671 creator A5013580704 @default.
• W2037393671 creator A5020876972 @default.
• W2037393671 creator A5023772267 @default.
• W2037393671 creator A5042115271 @default.
• W2037393671 creator A5071320890 @default.
• W2037393671 date "2012-01-01" @default.
• W2037393671 modified "2023-10-03" @default.
• W2037393671 title "Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries" @default.
• W2037393671 cites W1492125353 @default.
• W2037393671 cites W1984510851 @default.
• W2037393671 cites W1986748622 @default.
• W2037393671 cites W1992924018 @default.
• W2037393671 cites W2004909686 @default.
• W2037393671 cites W2007966374 @default.
• W2037393671 cites W2018430029 @default.
• W2037393671 cites W2022107377 @default.
• W2037393671 cites W2040877423 @default.
• W2037393671 cites W2052927293 @default.
• W2037393671 cites W2056405167 @default.
• W2037393671 cites W2057424922 @default.
• W2037393671 cites W2059380879 @default.
• W2037393671 cites W2067791971 @default.
• W2037393671 cites W2068327320 @default.
• W2037393671 cites W2068674226 @default.
• W2037393671 cites W2073438289 @default.
• W2037393671 cites W2077691379 @default.
• W2037393671 cites W2078181610 @default.
• W2037393671 cites W2079880019 @default.
• W2037393671 cites W2081724492 @default.
• W2037393671 cites W2085500628 @default.
• W2037393671 cites W2107555787 @default.
• W2037393671 cites W2114446989 @default.
• W2037393671 cites W2116214406 @default.
• W2037393671 cites W2128577982 @default.
• W2037393671 cites W2149048141 @default.
• W2037393671 cites W2152606399 @default.
• W2037393671 cites W2153311123 @default.
• W2037393671 cites W2158421794 @default.
• W2037393671 cites W4252639669 @default.
• W2037393671 doi "https://doi.org/10.1155/2012/841085" @default.
• W2037393671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3529905" @default.
• W2037393671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23304461" @default.
• W2037393671 hasPublicationYear "2012" @default.
• W2037393671 type Work @default.
• W2037393671 sameAs 2037393671 @default.
• W2037393671 citedByCount "32" @default.
• W2037393671 countsByYear W20373936712013 @default.
• W2037393671 countsByYear W20373936712014 @default.
• W2037393671 countsByYear W20373936712015 @default.
• W2037393671 countsByYear W20373936712016 @default.
• W2037393671 countsByYear W20373936712017 @default.
• W2037393671 countsByYear W20373936712018 @default.
• W2037393671 countsByYear W20373936712019 @default.
• W2037393671 countsByYear W20373936712020 @default.
• W2037393671 countsByYear W20373936712021 @default.
• W2037393671 countsByYear W20373936712022 @default.
• W2037393671 countsByYear W20373936712023 @default.
• W2037393671 crossrefType "journal-article" @default.
• W2037393671 hasAuthorship W2037393671A5002775050 @default.
• W2037393671 hasAuthorship W2037393671A5004751866 @default.
• W2037393671 hasAuthorship W2037393671A5013580704 @default.
• W2037393671 hasAuthorship W2037393671A5020876972 @default.
• W2037393671 hasAuthorship W2037393671A5023772267 @default.
• W2037393671 hasAuthorship W2037393671A5042115271 @default.
• W2037393671 hasAuthorship W2037393671A5071320890 @default.
• W2037393671 hasBestOaLocation W20373936711 @default.
• W2037393671 hasConcept C142724271 @default.
• W2037393671 hasConcept C144024400 @default.
• W2037393671 hasConcept C204787440 @default.
• W2037393671 hasConcept C2426938 @default.
• W2037393671 hasConcept C2779903281 @default.
• W2037393671 hasConcept C36289849 @default.
• W2037393671 hasConcept C512399662 @default.
• W2037393671 hasConcept C556039675 @default.
• W2037393671 hasConcept C56837625 @default.
• W2037393671 hasConcept C71924100 @default.
• W2037393671 hasConcept C98274493 @default.
• W2037393671 hasConceptScore W2037393671C142724271 @default.
• W2037393671 hasConceptScore W2037393671C144024400 @default.
• W2037393671 hasConceptScore W2037393671C204787440 @default.
• W2037393671 hasConceptScore W2037393671C2426938 @default.
• W2037393671 hasConceptScore W2037393671C2779903281 @default.
• W2037393671 hasConceptScore W2037393671C36289849 @default.
• W2037393671 hasConceptScore W2037393671C512399662 @default.
• W2037393671 hasConceptScore W2037393671C556039675 @default.
• W2037393671 hasConceptScore W2037393671C56837625 @default.
• W2037393671 hasConceptScore W2037393671C71924100 @default.
• W2037393671 hasConceptScore W2037393671C98274493 @default.
• W2037393671 hasFunder F4320310453 @default.
• W2037393671 hasLocation W20373936711 @default.
• W2037393671 hasLocation W20373936712 @default.
• W2037393671 hasLocation W20373936713 @default.
• W2037393671 hasLocation W20373936714 @default.
• W2037393671 hasLocation W20373936715 @default.

• next